2021 Drug Design and Delivery Symposium
We are continuing the theme of last year’s symposium and will feature more of the most innovative and revolutionary ideas in drug design and delivery. This year we have decided to increase the duration of each broadcast for an additional 30 minutes in the hope to dive deeper into each topic as well as answer more of your questions. The details for upcoming broadcasts will be posted as they are finalized.
|The Discovery of Sotorasib (AMG 510): First-in-Class Investigational Covalent Inhibitor of KRAS G12C
Brian Lanman - Amgen
Ariamala Gopalsamy - AstraZeneca
|Mar 31||An Integrated Approach: Oral Delivery of a Fatty Acid Acylated GLP-1 Peptide
Stephen Buckley - Novo Nordisk
Aktham Aburub - Eli Lilly and Company